Skip to main content
. 2016 Jul 5;11(7):e0157905. doi: 10.1371/journal.pone.0157905

Fig 5. Colocalization of human recombinant CAF22 with markers of fluid-phase and receptor-mediated endocytosis.

Fig 5

NT-/- mice were pretreated with leupeptin and injected 60 min later with human recombinant CAF22 in combination with either human recombinant transferrin or 10 kDa FITC-dextran. Mice were fixed by perfusion 10 min after injection and tissue sections stained for CAF22 (red) or human recombinant transferrin (green). FITC-dextran was detected as green staining. Cell nuclei were marked with DAPI (blue). Original magnification 1000 x.